|
Delayed
Bombay S.E.
10:23:21 14/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,251.55 INR | -0.42% |
|
-4.56% | +6.64% |
| 08-11 | Lupin Wins US FDA Nod for Abbreviated New Drug Application for Hyperkalemia Drug | MT |
| 08-10 | Lupin Gets FDA Approval for Hyperkalemia Drug | DJ |
| Market Cap | 1,034B 10.83B 9.39B 8.8B 8.03B 15.1B 15.34B 104B 40.46B 518B 40.67B 39.79B 1,726B | P/E 2027 * |
23.5x | P/E 2028 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise Value | 990B 10.37B 8.99B 8.43B 7.69B 14.46B 14.69B 99.25B 38.75B 496B 38.95B 38.1B 1,653B | EV / Sales 2027 * |
3.27x | EV / Sales 2028 * | 2.98x |
| Free-Float |
52.97% | Yield 2027 * |
0.56% | Yield 2028 * | 0.56% |
Last Transcript: Lupin Limited
| 1 day | -0.38% | ||
| 1 week | -4.56% | ||
| Current month | -6.70% | ||
| 1 month | -8.79% | ||
| 3 months | -0.24% | ||
| 6 months | +1.43% | ||
| Current year | +6.64% |
| 1 week | 2,233.1 |  | 2,366.2 |
| 1 month | 2,233.1 | | 2,530 |
| Current year | 2,072.95 | | 2,530 |
| 1 year | 1,881.8 | | 2,530 |
| 3 years | 1,061.25 | | 2,530 |
| 5 years | 583.05 | | 2,530 |
| 10 years | 505 | | 2,530 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 01/09/2013 | |
| Director of Finance/CFO | 61 | 13/08/2007 | |
Amit Kumar Gupta
CMP | Compliance Officer | - | 01/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 08/10/2008 | |
| Director/Board Member | 58 | 01/01/1997 | |
| Chairman | 82 | 11/08/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.42% | -4.56% | +14.92% | +108.22% | 10.83B | |
| -0.92% | +1.43% | +83.05% | +128.86% | 1,078B | |
| +0.47% | +1.98% | +50.26% | +50.75% | 632B | |
| +0.83% | +2.85% | +24.49% | +64.82% | 443B | |
| -0.88% | -0.66% | +45.09% | +36.64% | 356B | |
| -0.37% | -1.15% | +26.89% | +36.31% | 289B | |
| +0.05% | -1.20% | +2.31% | +6.15% | 245B | |
| +0.40% | +3.21% | +44.42% | +59.17% | 226B | |
| -0.42% | +1.58% | -8.48% | -51.94% | 204B | |
| +1.67% | +5.56% | +14.98% | +72.68% | 171B | |
| Average | +0.04% | +0.74% | +29.79% | +51.16% | 365.45B | |
| Weighted average by Cap. | -0.12% | +1.28% | +45.84% | +65.98% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 303B 3.18B 2.75B 2.58B 2.35B 4.43B 4.5B 30.38B 11.86B 152B 11.92B 11.66B 506B | 321B 3.36B 2.91B 2.73B 2.49B 4.69B 4.76B 32.17B 12.56B 161B 12.62B 12.35B 536B |
| Net income | 43.72B 458M 397M 372M 339M 639M 649M 4.38B 1.71B 21.88B 1.72B 1.68B 73B | 46.75B 490M 425M 398M 363M 683M 694M 4.69B 1.83B 23.4B 1.84B 1.8B 78.07B |
| Net Debt | -43.72B -458M -397M -372M -339M -639M -649M -4.38B -1.71B -21.88B -1.72B -1.68B -73B | -78.59B -823M -714M -669M -610M -1.15B -1.17B -7.88B -3.08B -39.34B -3.09B -3.02B -131B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | ₹2,251.55 | -0.42% | 20,413 |
| 13/08/26 | ₹2,261.00 | -0.16% | 18,184 |
| 12/08/26 | ₹2,264.70 | -0.58% | 22,350 |
| 11/08/26 | ₹2,278.00 | +0.13% | 158,968 |
| 10/08/26 | ₹2,275.00 | -3.60% | 196,912 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LUPIN Stock
Select your edition
All financial news and data tailored to specific country editions
